HomeCompareBLOK vs JNJ

BLOK vs JNJ: Dividend Comparison 2026

BLOK yields 0.82% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BLOK wins by $810.00 in total portfolio value
10 years
BLOK
BLOK
● Live price
0.82%
Share price
$49.81
Annual div
$0.41
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.8K
Annual income
$86.29
Full BLOK calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — BLOK vs JNJ

📍 BLOK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBLOKJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BLOK + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BLOK pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BLOK
Annual income on $10K today (after 15% tax)
$69.55/yr
After 10yr DRIP, annual income (after tax)
$73.35/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $630.27/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BLOK + JNJ for your $10,000?

BLOK: 50%JNJ: 50%
100% JNJ50/50100% BLOK
Portfolio after 10yr
$20.4K
Annual income
$457.03/yr
Blended yield
2.24%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

BLOK
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BLOK buys
0
JNJ buys
0
No recent congressional trades found for BLOK or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBLOKJNJ
Forward yield0.82%3.36%
Annual dividend / share$0.41$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$20.8K$20.0K
Annual income after 10y$86.29$827.78
Total dividends collected$842.00$5.6K
Payment frequencyquarterlyquarterly
SectorETFHealthcare

Year-by-year: BLOK vs JNJ ($10,000, DRIP)

YearBLOK PortfolioBLOK Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$10,782$81.82$10,676$355.77+$106.00BLOK
2$11,619$82.45$11,407$389.39+$212.00BLOK
3$12,515$83.04$12,198$426.53+$317.00BLOK
4$13,475$83.59$13,056$467.62+$419.00BLOK
5$14,502$84.11$13,987$513.12+$515.00BLOK
6$15,602$84.61$14,998$563.56+$604.00BLOK
7$16,779$85.07$16,098$619.52+$681.00BLOK
8$18,039$85.50$17,295$681.69+$744.00BLOK
9$19,388$85.91$18,599$750.82+$789.00BLOK
10$20,832$86.29$20,022$827.78+$810.00BLOK

BLOK vs JNJ: Complete Analysis 2026

BLOKETF

Amplify Blockchain Technology ETF1 (BLOK) navigates the future of blockchain and crypto investing by combining portfolio manager insights, risk management, and active decision making. BLOK invests at least 80% of its net assets in the equity securities of companies actively involved in the development and utilization of blockchain technologies. Blockchain is a technology that underpins cryptocurrencies like bitcoin. It is a peer-to-peer secure digital ledger that records and verifies tangible (Real World Assets), intangible, and digital assets across a network of computers.

Full BLOK Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this BLOK vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BLOK vs SCHDBLOK vs JEPIBLOK vs OBLOK vs KOBLOK vs MAINBLOK vs ABBVBLOK vs MRKBLOK vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.